Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.4M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
31.4M
-
Shares change
-
+3.09M
-
Total reported value, excl. options
-
$1.91B
-
Value change
-
+$209M
-
Put/Call ratio
-
1.58
-
Number of buys
-
96
-
Number of sells
-
-71
-
Price
-
$60.85
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2015
196 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2015.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.4M shares
of 80.4M outstanding shares and own 39.1% of the company stock.
Largest 10 shareholders include FMR LLC (5.05M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.34M shares), WELLINGTON MANAGEMENT GROUP LLP (2.3M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (1.65M shares), VANGUARD GROUP INC (1.63M shares), CREDIT SUISSE AG/ (1.19M shares), BB BIOTECH AG (1.18M shares), BlackRock Fund Advisors (1.11M shares), WELLS FARGO & COMPANY/MN (998K shares), and PUTNAM INVESTMENTS LLC (849K shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.